Purity 99% is not the whole result.

A chromatographic result describes what the method was designed to measure.

HPLC separates components in a sample and records signals under defined conditions. Purity may be calculated as the main peak's share of the total detected peak area. This is useful information about a chromatographic profile, but it depends on the method, detector, sample preparation and calculation rules.

ICH Q2(R2) distinguishes procedures used for identity, assay and purity or impurity evaluation. A procedure must be fit for its intended purpose. A “99% HPLC” result is therefore not automatically an identity result or a measurement of the amount inside a container.

THE KEY DISTINCTIONA high main-peak area describes the tested profile. By itself, it does not prove that the peak is the intended molecule or that the container holds the stated mass.

Identity, purity, assay and finished-material quality are not synonyms.

1. Identity

   Is the tested substance the intended molecule? This requires an appropriately specific identification procedure.

2. Purity and impurity profile

   Which other components were detected, and at what relative levels under the method used?

3. Assay or content

   How much of the intended material is actually present in the sample or container? This is different from relative peak area.

4. Finished-material quality

   Do the formulation, process, package and storage conditions maintain the required attributes throughout the stated period?

A good raw-material result does not automatically describe what happened next.

After testing, a substance may pass through formulation, filling, lyophilisation, closure, transport and storage. Each step can change the final risk profile. Documentation should therefore state exactly what was tested: raw material, lyophilised material, finished formulation or a sample taken after a defined stability period.

FDA CMC guidance treats drug-substance and finished-product specifications separately. Depending on the product form, microbiological attributes, particulates, container integrity and other fit-for-purpose controls may also matter. We use these documents as a framework for analytical thinking, not as a claim that every research-use product is governed by identical regulatory requirements.

Seven items worth finding in batch documentation.

1. Batch number

   It should connect the document to the material received.

2. Exact sample name and state

   Raw material, lyophilised material and a finished formulation are not the same test article.

3. Identity method

   The document should show how the intended molecule was confirmed.

4. Purity method and chromatogram

   A percentage without method context is difficult to interpret responsibly.

5. Assay or quantitative content

   This answers “how much?”, not only “what share of the signal?”.

6. Test date and laboratory

   The result should be traceable in time and to its performer.

7. Basis for storage conditions

   Stability claims should apply to the specific formulation, package and conditions.

Do not dismiss a 99% result. Put it in the right place.

Chromatographic purity is a valuable part of an assessment. It becomes misleading only when it is presented as the entire quality system. Strong documentation builds a traceable sequence from sample identity and impurity profile through assay, process and stability of the finished material.